Institutional Fund
Euclidean Capital LLC
New York, NYCIK 18250345 filings on record
Portfolio Value
$392.31M
Q1 2026
Holdings
10
Reported positions
New Buys
0
Opened this quarter
QoQ Change
+6.2%
from $369.45M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Vanguard Intl Equity Index F62.1%
- Vanguard Index Fds26.0%
- Ishares Tr4.4%
- Oric Pharmaceuticals Inc3.2%
- Foghorn Therapeutics Inc1.9%
- Pmv Pharmaceuticals Inc0.8%
- Other1.5%
Portfolio Holdings
10 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Vanguard Intl Equity Index F | 3.24M | $243.59M | 62.1% | +253.4K | Added |
| 2 | Vanguard Index Fds | 520.0K | $102.02M | 26.0% | 0 | Held |
| 3 | Ishares Tr | 369.6K | $17.31M | 4.4% | 0 | Held |
| 4 | Oric Pharmaceuticals Inc | 989.4K | $12.54M | 3.2% | 0 | Held |
| 5 | Foghorn Therapeutics Inc | 1.57M | $7.52M | 1.9% | 0 | Held |
| 6 | Pmv Pharmaceuticals Inc | 2.63M | $3.26M | 0.8% | 0 | Held |
| 7 | Alector Inc | 1.31M | $2.81M | 0.7% | 0 | Held |
| 8 | Surrozen Inc | 87.7K | $2.55M | 0.7% | 0 | Held |
| 9 | Tenaya Therapeutics Inc | 1.02M | $703.3K | 0.2% | 0 | Held |
| 10 | Surrozen Inc | 170.8K | $2.7K | 0.0% | 0 | Held |